DDW_Revvity_Event_Logo_400px copy-1
Revvity speaker_images_200px copy
Successful development of advanced biotherapeutics relies on extensive characterisation and tight quality control. Characterising binding properties of complex biomolecules is a critical step. Biophysical data combined with functional assays are needed to predict efficacy and potency, optimise drug delivery, assess critical quality attributes, and improve biologics drug design. 
Traditional approaches have limited use in a complex biological environment with multiple interactions. To address these challenges, the speakers have developed and implemented better-performing and higher throughput technologies.
In this webinar, the speakers will discuss: 
  • Method of testing the interaction of a lead biosimilar antibody candidate versus a commercially available antibody
  • Develop an assay to determine the level of binding activity 
  • Utilisation of the assay in QC lot release
  • An expression platform to aid early-stage clone screening and protein characterisation
  • Higher-throughput platform to streamline cell line development and characterisation workflows

An audience Q&A session with the presenters follows the webinar presentations.

Watch the webinar on-demand now!

Watch the Webinar